Nxera Pharma Co Ltd 4565
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 1,495.00
- Day Range
- JPY 1,453.00–1,505.00
- 52-Week Range
- JPY 1,296.00–3,185.00
- Bid/Ask
- JPY 1,455.00 / JPY 1,460.00
- Market Cap
- JPY 130.41 Bil
- Volume/Avg
- 3.1 Mil / 1.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 30.10
- Price/Sales
- 9.42
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nxera Pharma Co Ltd formerly Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 420
- Website
- http://www.sosei.com
Comparables
Valuation
|
Metric
|
4565
|
4563
|
4893
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.10 | — | — |
Price/Book Value | 1.95 | 0.37 | 1.32 |
Price/Sales | 9.42 | 60.63 | 22.64 |
Price/Cash Flow | — | — | — |
Price/Earnings
4565
4563
4893
Financial Strength
|
Metric
|
4565
|
4563
|
4893
|
|---|---|---|---|
Quick Ratio | 3.29 | 1.68 | 65.18 |
Current Ratio | 3.79 | 2.38 | 66.28 |
Interest Coverage | −3.82 | — | — |
Quick Ratio
4565
4563
4893
Profitability
|
Metric
|
4565
|
4563
|
4893
|
|---|---|---|---|
Return on Assets (Normalized) | −4.62% | −16.00% | −19.85% |
Return on Equity (Normalized) | −9.26% | −19.90% | −20.61% |
Return on Invested Capital (Normalized) | −4.48% | −19.26% | −20.61% |
Return on Assets
4565
4563
4893
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qthbmhfyc | Qkf | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Tyrqzdvp | Jdhbcmb | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Mqnrwgsc | Xpbjwbl | $97.8 Bil | |
MRNA
| Moderna Inc | Tfqqclzk | Hhqm | $41.3 Bil | |
ARGX
| argenx SE ADR | Mycccxrmt | Kcbd | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Xsprpfpm | Ltt | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zsbhclmz | Wbmqyd | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Jgzvknd | Cxmspm | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Plqxwzflb | Nrqsxp | $12.5 Bil | |
INCY
| Incyte Corp | Pdzwwdjpm | Krzkxy | $11.6 Bil |